Vivos Therapeutics is dedicated to transforming and improving lives by collaborating with top healthcare professionals and through innovative treatment modalities, advanced clinical protocols and solutions that may improve the overall health and wellness of people around the world.

Vivos believes that its Vivos System technology represents the first clinically effective non-surgical, non-invasive, non-pharmaceutical and cost-effective solution for people with mild-to-moderate OSA. Combining technologies and protocols that alter the size, shape and position of the tissues of the upper human airway, the Vivos System opens airway space and can possibly eliminate or significantly reduce symptoms and conditions associated with mild-to-moderate OSA.  The Vivos System has been shown to significantly lower Apnea Hypopnea Index scores and improve other conditions associated with OSA.  Sales of the Vivos System are driven by the Vivos Integrated Practice (VIP) program, which offers dentists training and value-added services in connection with their use of the Vivos System.

For more information, visit www.vivoslife.com
 


Dental

Health Care

Health Services

Medical Devices

Therapeutics

Vivos Institute

Corby Dixon

Bryan Denove

Kimberly MacIas-Salazar

Amanda Cruess

Brad Amman

Rosemarie Jewell

Operations and Fulfillment

AI Technologies

Business Development Team

Vivos Institute

Org chart

Teams

Operations and Fulfillment

AI Technologies

Business Development Team

Similar companies